Latest news

Debiopharm invests over 30 million on innovation when its workforce jumped 33% in Valais in one year

Transfer of Marketing Authorization of Anticancer Drug Elplat® to Takata Pharmaceutical

Debiopharm Innovation Fund Launches New Seed Funding Activity to accelerate digital transformation of cancer care and Pharma R&D

Debiopharm Recognizes Pioneering Japanese Cancer Research During The 82nd JCA-Mauvernay Award Ceremony

Debiopharm and SunRock Biopharma Partner to Advance Antibody Drug Conjugates for Hard-to-Treat Cancers

Debiopharm joins discussions with international health organisations to fight anti-microbial resistance at the 2023 World AMR Congress

Debiopharm Launches “Oncolifestyle” website in Switzerland for People Living with Cancer

8e Challenge Qualité de vie du patient : cinq finalistes reçoivent 5000 francs chacun et avancent en finale

Altis Labs Raises US $6 Million in Seed Funding Co-Led by Debiopharm and Benchstrength to Advance AI Platform for Clinical…